Mr. Ritter et Fs. Markland, Contortrostatin activates ERK2 and tyrosine phosphorylation events via distinct pathways, BIOC BIOP R, 274(1), 2000, pp. 142-148
Citations number
35
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
We report that cells adhering to contortrostatin show transient increases i
n activation of Extracellular signal Regulated Kinase 2 (ERK2). The kinetic
s and degree of activation are similar to cells adhering to fibronectin or
vitronectin. We have recently shown that contortrostatin induces tyrosine p
hosphorylation in tumor cells. Contortrostatin is shown here to stimulate a
ctivation of ERK2 in suspended cells, but this activation follows a differe
nt dose-response pattern than contortrostatin-induced tyrosine phosphorylat
ion. Since contortrostatin induces tyrosine phosphorylation via alpha v bet
a 3, we explored the effects of an alpha v beta 3-blocking antibody, 7E3, o
n contortrostatin-stimulated ERK2 activation. While 7E3 completely blocks t
he effect of contortrostatin on tyrosine phosphorylation, this antibody had
no effect on activation of ERK2. In cells lacking expression of alpha v be
ta 3, tyrosine phosphorylation was unaffected by contortrostatin treatment,
but ERK2 was activated. This is strong evidence that contortrostatin is re
gulating tyrosine phosphorylation events and ERK2 activation via separate p
athways and through different integrin receptors. (C) 2000 Academic Press.